Herborium Group progresses with Distribution Agreements for AcnEase and its Cosmeceuticals to take advantage of $8Billion French Cosmetic Market; - Seite 2

Herborium expects that with the present foundation in the French market coupled with it’s new distribution partners the Company will be able to increase AcnEase sales in France and its territories in 4^th Quarter of 2021, following with projected growth by as much as 50% in 2022.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics Company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements) and the burgeoning demand for natural wellness and beauty products.  The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products to establish and maintain a differential advantage. Herborium has develop a pipeline of botanical ingredients-based products in the areas of dermatological needs, wellness and antiaging, women’s health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com,  www.acnease.fr   and www.acneasesp.com

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed.  The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Attachment

• logo PR

CONTACT: Herborium Group, Inc.
Email: [e-mail] or [e-mail]